Transcriptomic and Proteomic Profiling of Circulating Tumor Cells to Identify Predictive Biomarkers of Chemotherapeutic Response in Triple-Negative Breast Cancer. ICMERD-IJMS. 2022;3(1):1-7. Accessed January 29, 2026. https://icmerd.org/index.php/ICMERD-IJMS/article/view/ICMERD-IJMS_03_01_001